KR910000183A - 재조합 포자충증 백신 - Google Patents
재조합 포자충증 백신 Download PDFInfo
- Publication number
- KR910000183A KR910000183A KR1019890007661A KR890007661A KR910000183A KR 910000183 A KR910000183 A KR 910000183A KR 1019890007661 A KR1019890007661 A KR 1019890007661A KR 890007661 A KR890007661 A KR 890007661A KR 910000183 A KR910000183 A KR 910000183A
- Authority
- KR
- South Korea
- Prior art keywords
- protein
- recombinant vector
- dna sequence
- host organism
- vaccine
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title claims 5
- 102000004169 proteins and genes Human genes 0.000 claims 15
- 108090000623 proteins and genes Proteins 0.000 claims 15
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 10
- 238000000034 method Methods 0.000 claims 7
- 244000144977 poultry Species 0.000 claims 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 239000002773 nucleotide Substances 0.000 claims 4
- 125000003729 nucleotide group Chemical group 0.000 claims 4
- 241000223924 Eimeria Species 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 230000000890 antigenic effect Effects 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 244000144972 livestock Species 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000002965 ELISA Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/455—Eimeria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 에이메리아 테넬라(Eimeria tenella)포자층의 ELISA의 결과를 도시한 것이다.
Claims (30)
- 약 28,37,120 또는 200킬로 달톤 이상의 겉보기 분자량을 가지고 아메리칸 타입 컬춰 콜렉션(American Type Culture collection)에 기탁번호 HB 9707 내지 9712로 기탁된 하나 이상의 모노클로날 항체와 특이적으로 결합하는 에이메리아(Eimeria) 표면 항원의 면역반응성 및/또는 항원성 결정소 하나 이상을 갖는 단백질.
- 제1항에 있어서, 제15도에 나타낸 아미노산 서열을 갖거나 이의 작용성 등가물인 단백질.
- 제1항에 있어서, 제17도에 나타낸 아미노산 서열을 갖거나 이의 작용성 등가물인 단백질.
- 제1항에 있어서, 제19도에 나타낸 아미노산 서열을 갖거나 이의 작용성 등가물인 단백질.
- 제1항에 있어서, 제21도에 나타낸 아미노산 서열을 갖거나 이의 작용성 등가물인 단백질.
- 제1항에 있어서, 5항 중 어느 한 항에 있어서 청구된 단백질을 암호화하는 DNA서열.
- 제6항에 있어서, 제14도에 나타낸 뉴클레오 타이드 서열 전체 또는 일부를 함유함을 특징으로 하는 DNA서열.
- 제6항에 있어서, 제16도에 나타낸 뉴클레오 타이드 서열 전체 또는 일부를 함유함을 특징으로 하는 DNA서열.
- 제6항에 있어서, 제18도에 나타낸 뉴클레오 타이드 서열 전체 또는 일부를 함유함을 특징으로 하는 DNA서열.
- 제6항에 있어서, 제20도에 나타낸 뉴클레오 타이드 서열 전체 또는 일부를 함유함을 특징으로 하는 DNA서열.
- 제6항 내지 10항 중 어느 한 항에 있어서 청구된 DNA 서열을 함유함을 특징으로 하는 재조합 벡터.
- 제11항에 있어서, 재조합 벡터가 적합한 숙주 유기체에서 DNA 서열의 발현을 지시할 수 있는 재조합 벡터.
- 제11항 또는 12항에 있어서, 폭스바이러스(poxvirus)벡터인 재조합 백터.
- 제11항 또는 12항에 있어서, 이. 콜라이(E.coli)벡터인 재조합 백터.
- 제14항에 있어서, PEV /2-4인 재조합 벡터.
- 제11항 내지 15항 중 어느 한 항에서 청구된 재조합 벡터로 형질전환된 숙주 유기체.
- 제16항에 있어서, 재조합 벡터내에 함유된 제1항 내지 5항중 어느 한 항에 따른 단백질의 암호와 DNA서열을 발현할 수 있는 형질전환된 숙주 유기체.
- 제1항 내지 5항 중 어느 한 항에서 청구된 단백질에 대한 항체.
- 제18항에 있어서, 모노클로날 항체인 항체.
- 제19항에 있어서, ATCC HB 9707, HB 9708, HB 9709, HB 9710, HB9711 및 HB 9712로 이루어진 그룹중에서 선택되는 모노클로날 항체.
- 제1 내지 5항에 있어서, 포자충증에 대한 가금의 면역화를 위한 단백질.
- (a) 제1항 내지 5항 중 어느 한 항에서 청구된 단백질을 암호화하는 DNA서열을 함유하는 재조합 벡터로 형질전환된 숙주 유기체를 DNA 서열이 발현되는 조건하에서 배양하고, (b) 배양물로부터 단백질을 분리함을 특징으로 하는, 제1항 내지 5항 중 어느 한 항에서 청구된 단백질의 제조방법.
- 공지된 방법을 사용하여 제11항 내지 15항 중 어느 한 항에서 청구된 재조합 벡터로 숙주 유기체를 형질전환시킴을 특징으로 하는, 제16항 또는 17항에서 청구된 형질 전환된 숙주 유기체의 제조방법.
- 제1항 내지 5항 중 어느 한 항에 따른 단백질 하나 이상 및 생리학적으로 허용되는 담체를 함유함을 특징으로 하는, 포자충증에 대해 가금을 보호하기 위한 백신.
- 제13항에 따른 재조합 폭스바이러스 벡터를 함유함을 특징으로 하는, 포자충증에 대해 가금을 보호하기 위한 백신.
- 포자충증에 대해 가금을 보호할 수 있는 백신의 제조를 위한 제1항 내지 5항 중 어느 한 항에 따른 단백질의 용도.
- 제1항 내지 5항 중 어느 한 항에 있어서, 제22항에서 청구된 방법에 의해 제조되는 단백질.
- 제16항 또는 17항에 있어서, 제23항에서 청구된 방법에 의해 제조되는 형질전환된 숙주 유기체.
- 상기에 설명한 것과 같은 발명.
- 포자충증에 약한 어린 가축에 제24항 또는 25항에서 청구된 백신의 유효량을 투여함을 특징으로 하여, 포자충증에 대해 가금을 보호하는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20272188A | 1988-06-03 | 1988-06-03 | |
US202,721 | 1988-06-03 | ||
US202721 | 1988-06-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR910000183A true KR910000183A (ko) | 1991-01-29 |
KR0156545B1 KR0156545B1 (ko) | 1998-11-16 |
Family
ID=22750986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890007661A KR0156545B1 (ko) | 1988-06-03 | 1989-06-03 | 재조합 포자충증 백신 |
Country Status (22)
Country | Link |
---|---|
US (2) | US5661015A (ko) |
EP (1) | EP0344808B1 (ko) |
JP (1) | JP3051130B2 (ko) |
KR (1) | KR0156545B1 (ko) |
CN (3) | CN1040126C (ko) |
AR (1) | AR241942A1 (ko) |
AT (1) | ATE120489T1 (ko) |
AU (1) | AU635704B2 (ko) |
CA (1) | CA1340538C (ko) |
DE (1) | DE68921923T2 (ko) |
DK (1) | DK272889A (ko) |
ES (1) | ES2070866T3 (ko) |
FI (1) | FI101453B (ko) |
HU (1) | HU212505B (ko) |
IE (1) | IE67544B1 (ko) |
IL (1) | IL90489A0 (ko) |
MC (1) | MC2039A1 (ko) |
NO (1) | NO303876B1 (ko) |
NZ (1) | NZ229377A (ko) |
PT (1) | PT90727B (ko) |
YU (1) | YU47880B (ko) |
ZA (1) | ZA893740B (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100490669B1 (ko) * | 2001-08-30 | 2005-05-19 | (주)아비코아생명공학연구소 | 조류 콕시듐증을 유발하는 에이메리아 종의 포자소체 표면항원에 대한 scFv 재조합 항체 |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5174993A (en) * | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
US5279960A (en) * | 1984-07-05 | 1994-01-18 | Enzon Corp. | 25 KD coccidial antigen of eimeria tenella |
US5273901A (en) * | 1984-07-05 | 1993-12-28 | Enzon Corp. | Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b |
US5824656A (en) * | 1988-01-15 | 1998-10-20 | Merck & Co., Inc. | Recombinant and native group B eimeria tenella immunogens useful as coccidiosis vaccines |
DE68927350T2 (de) * | 1988-07-05 | 1997-04-24 | British Tech Group Usa | Gentechnologisch hergestellter coccidiose-impfstoff |
ZA902147B (en) * | 1989-03-28 | 1990-12-28 | Akzo Nv | Coccidiosis vaccine |
ATE94208T1 (de) * | 1989-06-21 | 1993-09-15 | Akzo Nv | Eimeria tenella-vakzin. |
ZA9010461B (en) * | 1990-01-26 | 1991-10-30 | Hoffmann La Roche | Recombinant coccidiosis vaccines-5-7 eimeria surface antigen |
JPH07500483A (ja) * | 1991-03-14 | 1995-01-19 | ブリティッシュ・テクノロジー・グループ・ユーエスエイ・インコーポレーテッド | 組換え体抗コクシジアワクチン |
US6008342A (en) * | 1991-07-12 | 1999-12-28 | Roche Vitamins Inc. | DNA encoding eimeria antigen |
US5403581A (en) * | 1991-07-12 | 1995-04-04 | Hoffmann-La Roche Inc. | Coccidiosis vaccines |
JP3534774B2 (ja) | 1995-06-07 | 2004-06-07 | ファイザー・インク | コクシジウム症に対する卵内予防接種 |
US6500438B2 (en) | 1995-06-07 | 2002-12-31 | Pfizer Incorporated | In ovo vaccination against coccidiosis |
ES2253746T3 (es) * | 1995-07-03 | 2006-06-01 | Akzo Nobel N.V. | Vacuna contra la coccidiosis aviar. |
AU2590997A (en) * | 1996-03-29 | 1997-10-22 | Life Technologies, Inc. | Method for increasing viability and transformation efficiency of bacteria during storage at low temperatures |
US6632923B1 (en) * | 1996-11-27 | 2003-10-14 | Boston Heart Foundation, Inc. | Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
US6627205B2 (en) | 1997-12-01 | 2003-09-30 | Pfizer Incorporated | Ovo vaccination against coccidiosis |
US6984378B1 (en) | 1999-02-26 | 2006-01-10 | Pfizer, Inc. | Method for the purification, recovery, and sporulation of cysts and oocysts |
ZA200400479B (en) * | 2001-07-06 | 2006-05-31 | Abic Biolog Lab Teva | Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use |
WO2003020917A1 (en) | 2001-08-30 | 2003-03-13 | Embrex, Inc. | Improved methods for producing oocysts |
JP3995541B2 (ja) * | 2002-06-28 | 2007-10-24 | 株式会社ゲン・コーポレーション | 抗鶏コクシジウム症組成物 |
DE10330235A1 (de) * | 2003-07-04 | 2005-01-20 | Bayer Healthcare Ag | Neues Eimeria Gen und Protein sowie deren Verwendung |
US7348401B2 (en) * | 2003-09-10 | 2008-03-25 | Innate Biotech, Inc. | Peptides that inhibit complement activation |
DE602005021873D1 (de) * | 2004-03-12 | 2010-07-29 | Univ Georgia | Neues impfstoffadjuvans und dessen herstellung und verwendung |
US7087425B2 (en) * | 2004-03-31 | 2006-08-08 | Embrex, Inc. | Method of purifying oocysts using enzymatic digestion of fecal debris |
US20110078828A1 (en) * | 2004-09-10 | 2011-03-31 | Guardian Biotechnologies Inc. | Multi epitope vaccine for poultry |
DE602005003429T2 (de) * | 2004-12-01 | 2008-10-02 | Zeon Corp. | Kodierende DNS für ein Eimeria Apical Membran Antigen 1 und dessen Verwendungen |
CN100398156C (zh) * | 2005-11-23 | 2008-07-02 | 南京农业大学 | 用于预防鸡球虫病的免疫调节型dna疫苗 |
US20080194006A1 (en) * | 2007-02-08 | 2008-08-14 | Embrex, Inc. | Methods of releasing sporocysts from oocysts using controlled shear forces |
US11701683B2 (en) | 2010-12-22 | 2023-07-18 | The Procter & Gamble Company | Methods for foil stamping parts having asymmetrical edges |
US10758601B2 (en) | 2016-12-22 | 2020-09-01 | Intervet Inc. | Eimeria vaccine with improved efficacy |
WO2020243240A1 (en) * | 2019-05-28 | 2020-12-03 | Case Western Reserve University | Compositions and methods for preserving dna methylation |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4237224A (en) | 1974-11-04 | 1980-12-02 | Board Of Trustees Of The Leland Stanford Jr. University | Process for producing biologically functional molecular chimeras |
DE2814039C3 (de) | 1978-03-31 | 1981-02-19 | Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig | Verfahren zur Herstellung von Hybrid-Bakterien |
EP0135073A3 (en) * | 1983-08-19 | 1987-05-27 | American Cyanamid Company | Antigens and monoclonal antibodies reactive against merozites of eimeria spp. |
US4650676A (en) | 1983-08-19 | 1987-03-17 | American Cyanamid Company | Antigens and monoclonal antibodies reactive against merozoites of Eimeria spp. |
US4710377A (en) * | 1983-08-19 | 1987-12-01 | American Cyanamid Company | Antigens and monoclonal antibodies reactive against sporozoites of Eimeria spp. |
EP0135712A3 (en) * | 1983-08-19 | 1987-05-27 | American Cyanamid Company | Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp. |
US4874705A (en) * | 1985-05-16 | 1989-10-17 | Solvay & Cie, S.A. | DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella |
US5187080A (en) * | 1984-06-05 | 1993-02-16 | Solvay & Cie S.A. | DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella |
CA1340520C (en) * | 1984-06-05 | 1999-05-04 | Karel Z. Newman Jr. | Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix |
US4639372A (en) | 1984-06-29 | 1987-01-27 | Merck & Co., Inc. | Coccidiosis vaccine |
WO1986000528A1 (en) * | 1984-07-05 | 1986-01-30 | Genex Corporation | Cloned gene and method for making and using the same |
US5273901A (en) * | 1984-07-05 | 1993-12-28 | Enzon Corp. | Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b |
ES2109254T3 (es) * | 1985-12-03 | 1998-01-16 | Dimminaco Ag Sa Ltd | Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis. |
EP0241139A3 (en) * | 1986-03-13 | 1989-04-19 | Merck & Co. Inc. | Anti-idiotypic vaccine for coccidiosis |
US5496550A (en) * | 1986-08-14 | 1996-03-05 | Chilwalner | Method of reducing the output of Eimeria oocysts from a newborn chick |
ATE145245T1 (de) * | 1987-03-06 | 1996-11-15 | Amgen Boulder Inc | Polypeptide zur verwendung bei der diagnose von kokkidien-infektion und rekombinant-dns, verfahren zur herstellung derselben |
EP0315073A2 (en) * | 1987-11-02 | 1989-05-10 | Matsushita Electric Industrial Co., Ltd. | A composition for pattern forming materials |
NZ227595A (en) * | 1988-01-15 | 1991-11-26 | Merck & Co Inc | Recombinant production of eimeria tenella antigens and their use |
NZ227597A (en) * | 1988-01-15 | 1991-11-26 | Merck & Co Inc | Eimeria tenella group b immunogens and their production |
AU620366B2 (en) * | 1988-02-12 | 1992-02-20 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Cloned genes coding for avian coccidiosis antigens which induce a cell-mediated response and method of producing the same |
DE3926461A1 (de) * | 1989-07-15 | 1991-01-24 | Suttner Gmbh & Co Kg | Ventilpistole, insbesondere fuer ein hochdruckreinigungsgeraet |
-
1989
- 1989-05-18 ZA ZA893740A patent/ZA893740B/xx unknown
- 1989-06-01 IL IL90489A patent/IL90489A0/xx unknown
- 1989-06-01 AR AR89314066A patent/AR241942A1/es active
- 1989-06-01 NZ NZ229377A patent/NZ229377A/en unknown
- 1989-06-02 AT AT89110056T patent/ATE120489T1/de not_active IP Right Cessation
- 1989-06-02 AU AU36016/89A patent/AU635704B2/en not_active Ceased
- 1989-06-02 DK DK272889A patent/DK272889A/da not_active Application Discontinuation
- 1989-06-02 HU HU892814A patent/HU212505B/hu not_active IP Right Cessation
- 1989-06-02 PT PT90727A patent/PT90727B/pt not_active IP Right Cessation
- 1989-06-02 NO NO892251A patent/NO303876B1/no not_active IP Right Cessation
- 1989-06-02 MC MC892053A patent/MC2039A1/xx unknown
- 1989-06-02 CA CA000601631A patent/CA1340538C/en not_active Expired - Fee Related
- 1989-06-02 FI FI892714A patent/FI101453B/fi not_active IP Right Cessation
- 1989-06-02 DE DE68921923T patent/DE68921923T2/de not_active Expired - Fee Related
- 1989-06-02 EP EP89110056A patent/EP0344808B1/en not_active Expired - Lifetime
- 1989-06-02 YU YU113889A patent/YU47880B/sh unknown
- 1989-06-02 ES ES89110056T patent/ES2070866T3/es not_active Expired - Lifetime
- 1989-06-03 CN CN89104278A patent/CN1040126C/zh not_active Expired - Fee Related
- 1989-06-03 KR KR1019890007661A patent/KR0156545B1/ko not_active IP Right Cessation
- 1989-06-03 JP JP1140268A patent/JP3051130B2/ja not_active Expired - Lifetime
- 1989-06-12 IE IE181289A patent/IE67544B1/en not_active IP Right Cessation
-
1991
- 1991-12-20 US US07/812,349 patent/US5661015A/en not_active Expired - Lifetime
-
1997
- 1997-09-22 CN CN97119228A patent/CN1076204C/zh not_active Expired - Fee Related
- 1997-09-22 CN CN97118698A patent/CN1077438C/zh not_active Expired - Fee Related
-
2002
- 2002-10-09 US US10/267,430 patent/US20030175311A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100490669B1 (ko) * | 2001-08-30 | 2005-05-19 | (주)아비코아생명공학연구소 | 조류 콕시듐증을 유발하는 에이메리아 종의 포자소체 표면항원에 대한 scFv 재조합 항체 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR910000183A (ko) | 재조합 포자충증 백신 | |
Wright et al. | The development of a recombinant Babesia vaccine | |
RU2432364C2 (ru) | ПОЛИКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВ Nogo, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ПРИМЕНЕНИЕ АНТИТЕЛА ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА | |
AU585512B2 (en) | Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix | |
SK56394A3 (en) | Anti-vaccine of streptococcus suis infection and method of its production | |
Schaefer et al. | Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis | |
US20150293118A1 (en) | Cross-reactive determinants and methods for their identification | |
KR900013983A (ko) | 콕시디오시스 왁찐 | |
Nelson et al. | Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: immunosuppression, immunogenicity, and relation to immunosuppressive tumor products | |
Fernandez et al. | Protective effect against Rhodococcus equi infection in mice of IgG purified from horses vaccinated with virulence associated protein (VapA)-enriched antigens | |
EP0603406B1 (en) | Fowl mycoplasma antigen, gene thereof, recombinant vector containing said gene, and vaccine prepared by utilizing the same | |
CA2180309A1 (en) | Coccidiosis poultry vaccine | |
Seed | Trypanosoma gambiense and T. equiperdum: Characterization of variant specific antigens | |
Srivastava et al. | Specificity and inhibitory activity of antibodies to Plasmodium falciparum aldolase. | |
US7279167B2 (en) | Infectious Salmon Anaemia virus vaccine | |
US6203801B1 (en) | Coccidiosis polypeptide and vaccines | |
Mahoney et al. | Immunization against babesiosis: current studies and future outlook | |
WO1995020658A3 (en) | Diagnosis and treatment of infections due to streptococci and enterococci | |
KR930703445A (ko) | 톡소플라스마 곤디(toxoplasma gondii)의 단백질 항원의 클로닝 및 발현 | |
Takagi et al. | Purification of hemagglutinin from Haemophilus paragallinarum using monoclonal antibody | |
US20020006408A1 (en) | Vaccines against eimeria mediated disorder | |
US6680061B1 (en) | Coccidiosis vaccines | |
CN104450626B (zh) | 抗chMDA5蛋白单克隆抗体及其制备方法和应用 | |
EP0872486A1 (en) | Eimeria proteins as vaccines | |
ZA906667B (en) | Antigens and polypeptides derived from babesia(12d3 antigen) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20070102 Year of fee payment: 9 |
|
LAPS | Lapse due to unpaid annual fee |